Gudrun Hefner
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 16
- Electroconvulsive Therapy Studies 6
- Pharmacology 13
- Treatment of Major Depression 11
- Co-authors
- Christoph Hiemke (24 shared papers)A. Klimke (10 shared papers)Tanja Falter (7 shared papers)Stefan Unterecker (5 shared papers)Sermin Toto (8 shared papers)Jan Wolff (8 shared papers)Mohamed E. E. Shams (3 shared papers)Martina Hahn (7 shared papers)
- Journals
- Journal of Neural Transmission (7 papers)Pharmacopsychiatry (4 papers)Frontiers in Psychiatry (2 papers)Therapeutic Drug Monitoring (2 papers)Psychopharmacology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Gudrun Hefner
32 papers receiving 540 citations
Peers
Comparison fields: 5 of 83
- Geriatrics and Gerontology 112
- Biological Psychiatry 44
- Psychiatry and Mental health 218
- Toxicology 32
- Pharmacology 127
Countries citing papers authored by Gudrun Hefner
This map shows the geographic impact of Gudrun Hefner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gudrun Hefner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gudrun Hefner more than expected).
Fields of papers citing papers by Gudrun Hefner
This network shows the impact of papers produced by Gudrun Hefner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gudrun Hefner. The network helps show where Gudrun Hefner may publish in the future.
Co-authors
The 25 scholars most cited alongside Gudrun Hefner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 62 | |
| 2 | 2017 | 40 | |
| 3 | 2014 | 39 | |
| 4 | 2020 | 35 | |
| 5 | 2021 | 30 | |
| 6 | 2021 | 25 | |
| 7 | 2014 | 24 | |
| 8 | 2014 | 24 | |
| 9 | 2020 | 21 | |
| 10 | 2020 | 20 | |
| 11 | 2018 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2020 | 18 | |
| 14 | 2015 | 18 | |
| 15 | 2013 | 17 | |
| 16 | 2014 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2022 | 15 | |
| 19 | 2018 | 15 | |
| 20 | Rating The Delirogenic Potential of Drugs for Prediction of Side Effects in Elderly Psychiatric Inpatients | 2015 | 10 |
About Gudrun Hefner
Gudrun Hefner is a scholar working on Psychiatry and Mental health, Pharmacology, Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine, having authored 33 papers that have together received 549 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (16 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Treatment of Major Depression (11 papers), Electroconvulsive Therapy Studies (6 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmaceutical studies and practices (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Tryptophan and brain disorders (3 papers). The work is most often cited by research in Geriatrics and Gerontology (112 citations), Biological Psychiatry (44 citations), Psychiatry and Mental health (218 citations), Toxicology (32 citations) and Pharmacology (127 citations). Gudrun Hefner has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Christoph Hiemke, A. Klimke, Tanja Falter, Stefan Unterecker, Sermin Toto, Jan Wolff, Mohamed E. E. Shams, Martina Hahn, Ursula Voss and Christian Freese. Their work appears in journals such as Journal of Neural Transmission, Pharmacopsychiatry, Frontiers in Psychiatry, Therapeutic Drug Monitoring and Psychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.